99mTc HYNIC-TOC imaging and 177Lu DOTA-octreotate treatment in non-iodine-concentrating dedifferentiated thyroid carcinoma metastases: an unusual alternative diagnosis

dc.contributor.authorBasu, Sandip
dc.contributor.authorJoshi, A.
dc.date.accessioned2015-07-29T10:16:03Z
dc.date.available2015-07-29T10:16:03Z
dc.date.issued2014
dc.description.divisionRMCen
dc.format.extent4038 bytes
dc.format.mimetypetext/html
dc.identifier.sourceClinical Nuclear Medicine, 2014. Vol. 39 (7): pp. 632-634en
dc.identifier.urihttp://hdl.handle.net/123456789/11441
dc.language.isoenen
dc.subjectpapillary thyroid carcinomaen
dc.subjectneuroendocrine tumoren
dc.subjectpeptide receptor radionuclide therapyen
dc.subject177Lu DOTA-octreotate therapyen
dc.subject99mTc HYNIC-TOCen
dc.subjectsomatostatin receptor scintigraphyen
dc.title99mTc HYNIC-TOC imaging and 177Lu DOTA-octreotate treatment in non-iodine-concentrating dedifferentiated thyroid carcinoma metastases: an unusual alternative diagnosisen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1507.htm
Size:
3.94 KB
Format:
Hypertext Markup Language
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections